Metsera, Inc. (MTSR)
NASDAQ: MTSR · Real-Time Price · USD
29.60
+1.89 (6.82%)
At close: Jun 20, 2025, 4:00 PM
29.40
-0.20 (-0.68%)
After-hours: Jun 20, 2025, 7:29 PM EDT
Metsera Market Cap
Metsera has a market cap or net worth of $3.11 billion as of June 20, 2025.
Market Cap
3.11B
Enterprise Value
2.53B
1-Year Change
n/a
Ranking
Category
Stock Price
29.60
Market Cap Chart
Since January 31, 2025, Metsera's market cap has increased from $2.73B to $3.11B, an increase of 13.89%. That is a compound annual growth rate of 40.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 20, 2025 | 3.11B | 6.82% |
Jun 18, 2025 | 2.91B | 9.18% |
Jun 17, 2025 | 2.67B | -5.55% |
Jun 16, 2025 | 2.82B | -8.54% |
Jun 13, 2025 | 3.09B | -15.04% |
Jun 12, 2025 | 3.63B | 4.60% |
Jun 11, 2025 | 3.47B | -5.81% |
Jun 10, 2025 | 3.69B | 15.50% |
Jun 9, 2025 | 3.19B | 10.55% |
Jun 6, 2025 | 2.89B | -4.12% |
Jun 5, 2025 | 3.01B | 0.31% |
Jun 4, 2025 | 3.00B | -2.62% |
Jun 3, 2025 | 3.08B | 4.37% |
Jun 2, 2025 | 2.95B | 5.24% |
May 30, 2025 | 2.81B | -3.15% |
May 29, 2025 | 2.90B | -1.50% |
May 28, 2025 | 2.94B | 0.65% |
May 27, 2025 | 2.92B | 1.94% |
May 23, 2025 | 2.87B | -2.66% |
May 22, 2025 | 2.95B | -2.21% |
May 21, 2025 | 3.01B | -1.95% |
May 20, 2025 | 3.07B | 1.00% |
May 19, 2025 | 3.04B | -1.90% |
May 16, 2025 | 3.10B | 15.27% |
May 15, 2025 | 2.69B | 4.57% |
May 14, 2025 | 2.57B | -6.17% |
May 13, 2025 | 2.74B | -1.06% |
May 12, 2025 | 2.77B | 10.52% |
May 9, 2025 | 2.51B | -3.59% |
May 8, 2025 | 2.60B | 7.00% |
May 7, 2025 | 2.43B | 1.76% |
May 6, 2025 | 2.39B | -5.17% |
May 5, 2025 | 2.52B | -6.51% |
May 2, 2025 | 2.69B | 9.80% |
May 1, 2025 | 2.45B | -3.11% |
Apr 30, 2025 | 2.53B | 3.48% |
Apr 29, 2025 | 2.45B | 17.62% |
Apr 28, 2025 | 2.08B | 6.91% |
Apr 25, 2025 | 1.95B | -12.51% |
Apr 24, 2025 | 2.22B | -10.18% |
Apr 23, 2025 | 2.48B | 8.76% |
Apr 22, 2025 | 2.28B | 11.12% |
Apr 21, 2025 | 2.05B | -0.31% |
Apr 17, 2025 | 2.06B | 11.51% |
Apr 16, 2025 | 1.84B | 2.27% |
Apr 15, 2025 | 1.80B | -5.61% |
Apr 14, 2025 | 1.91B | 29.86% |
Apr 11, 2025 | 1.47B | 7.03% |
Apr 10, 2025 | 1.37B | -14.34% |
Apr 9, 2025 | 1.60B | 7.46% |
Apr 8, 2025 | 1.49B | -13.62% |
Apr 7, 2025 | 1.73B | -2.08% |
Apr 4, 2025 | 1.76B | -20.57% |
Apr 3, 2025 | 2.22B | -6.66% |
Apr 2, 2025 | 2.38B | -7.55% |
Apr 1, 2025 | 2.57B | -9.96% |
Mar 31, 2025 | 2.86B | -2.79% |
Mar 28, 2025 | 2.94B | -6.70% |
Mar 27, 2025 | 3.15B | 6.76% |
Mar 26, 2025 | 2.95B | -3.85% |
Mar 25, 2025 | 3.07B | -3.03% |
Mar 24, 2025 | 3.17B | 7.32% |
Mar 21, 2025 | 2.95B | 0.72% |
Mar 20, 2025 | 2.93B | -6.83% |
Mar 19, 2025 | 3.15B | -1.55% |
Mar 18, 2025 | 3.19B | 6.87% |
Mar 17, 2025 | 2.99B | 12.57% |
Mar 14, 2025 | 2.66B | 3.92% |
Mar 13, 2025 | 2.56B | -5.90% |
Mar 12, 2025 | 2.72B | 3.29% |
Mar 11, 2025 | 2.63B | -0.28% |
Mar 10, 2025 | 2.64B | -1.73% |
Mar 7, 2025 | 2.68B | -5.39% |
Mar 6, 2025 | 2.84B | 1.89% |
Mar 5, 2025 | 2.78B | -3.89% |
Mar 4, 2025 | 2.90B | -3.54% |
Mar 3, 2025 | 3.00B | 15.01% |
Feb 28, 2025 | 2.61B | -0.92% |
Feb 27, 2025 | 2.63B | -8.09% |
Feb 26, 2025 | 2.87B | -0.44% |
Feb 25, 2025 | 2.88B | -8.32% |
Feb 24, 2025 | 3.14B | -5.81% |
Feb 21, 2025 | 3.33B | 0.03% |
Feb 20, 2025 | 3.33B | -0.85% |
Feb 19, 2025 | 3.36B | -0.53% |
Feb 18, 2025 | 3.38B | 4.91% |
Feb 14, 2025 | 3.22B | 1.83% |
Feb 13, 2025 | 3.16B | -5.12% |
Feb 12, 2025 | 3.33B | 2.89% |
Feb 11, 2025 | 3.24B | 2.26% |
Feb 10, 2025 | 3.17B | 1.97% |
Feb 7, 2025 | 3.11B | -0.10% |
Feb 6, 2025 | 3.11B | 0.96% |
Feb 5, 2025 | 3.08B | 6.75% |
Feb 4, 2025 | 2.89B | 0.76% |
Feb 3, 2025 | 2.86B | 4.91% |
Jan 31, 2025 | 2.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 704.75B |
Johnson & Johnson | 362.67B |
Novo Nordisk | 333.14B |
AbbVie | 327.65B |
UnitedHealth Group | 278.67B |
Abbott Laboratories | 230.37B |
Novartis AG | 227.73B |
AstraZeneca | 219.65B |